The global biosimilar monoclonal antibody market revenue was around US$ 10.6 billion in 2023 and is estimated to reach US$ 64.7 billion by 2032, growing at a compound annual growth rate (CAGR) of 22.2 ...
His nomination to be HHS secretary is a threat to American medical innovation.
Cases of RSV and flu are ticking up among young children in the U.S. even as overall respiratory virus activity remains low, ...
Sixty percent of a surveyed group of U.S adults said they would "probably not" get a booster vaccine this winter.
The findings of a study into the effect of COVID-19 vaccines on children are being misrepresented in posts shared on social ...
Researchers review the safety, efficacy, and considerations for COVID-19 vaccination in multiple sclerosis patients, ...
Heading into the fifth U.S. winter of COVID-19, an Emory University lab has found the presence – or absence – of a particular ...
CHENNAI: A seroprevalence study conducted by the State Public Health Laboratory, Directorate of Public Health and Preventive ...